Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database

To assess the impact of lymphovascular invasion (LVI) on the risk of biochemical recurrence (BCR) in pT3 N0 prostate cancer, clinical data were extracted from 1,622 patients with pT3 N0 prostate cancer from the K-CaP database. Patients with neoadjuvant androgen deprivation therapy (n = 325) or insuf...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yong Hyun, Kim, Yejin, Yu, Hwanjo, Choi, In Young, Byun, Seok-Soo, Kwak, Cheol, Chung, Byung Ha, Lee, Hyun Moo, Kim, Choung Soo, Lee, Ji Youl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857072/
https://www.ncbi.nlm.nih.gov/pubmed/27146602
http://dx.doi.org/10.1038/srep25419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857072/
https://www.ncbi.nlm.nih.gov/pubmed/27146602
http://dx.doi.org/10.1038/srep25419

Ejemplares similares